Investor profile for Fusion Fund: typical check size, headquarters (Palo Alto, CA), stages they lead or invest in, and links to website and social profiles. Part of the Venture Capital Tracker directory.
Lu Zhang's Palo Alto firm backing early-stage deep-tech, healthcare, and enterprise AI companies with technical or data moats. Deploying from Fund IV ($190M, closed March 2025).
Stage fit, check size, thesis, and how founders typically approach this firm — based on public sources and our directory.
Fusion Fund focuses on early-stage companies, primarily Seed and Series A. The firm often acts as an early institutional investor and can lead or co-lead those rounds.
Fusion Fund has publicly described initial checks in roughly the $500K–$5M range at seed and Series A, with many investments around $1M–$3M. Our directory stage estimate for firms at this profile is $1M–$10M.
Fusion Fund is headquartered in Palo Alto, California. Public materials emphasize U.S. and Canada investments, with a Silicon Valley–anchored network.
Fusion Fund invests in deep tech with defensible technical or data advantages — especially healthcare, enterprise AI, and industrial technology. Founder Lu Zhang emphasizes technical diligence and commercializing hard-science innovation.
Fusion Fund frequently leads or co-leads seed and Series A rounds as an early institutional partner, and reserves capital for follow-ons in portfolio companies.
We do not yet have startups in the Venture Capital Tracker directory with Fusion Fund listed as an investor. Their public portfolio spans healthcare AI, robotics, and enterprise software — check fusionfund.com for current companies.
Start on fusionfund.com and LinkedIn to identify the right partner for your sector. Like most seed firms, warm introductions from trusted operators or co-investors help; avoid cold mass emails to generic inboxes.
Fusion Fund is referenced in our NYC and early-stage investor guides as a deep-tech seed investor. We do not yet have a dedicated fund-close article — see /directory for related firms in healthtech and AI.
